Medicines, Poisons and Therapeutic Goods Amendment Regulation 2020 (No 3) (ACT)
Medicines, Poisons and Therapeutic Goods Amendment Regulation 2020 (No 3)
Subordinate Law SL2020-24
The Australian Capital Territory Executive makes the following regulation under the Medicines, Poisons and Therapeutic Goods Act 2008.
Dated 26 June 2020.
Rachel Stephen-Smith
Minister
Shane Rattenbury
Minister
Medicines, Poisons and Therapeutic Goods Amendment Regulation 2020 (No 3)
Subordinate Law SL2020-24
made under the
Medicines, Poisons and Therapeutic Goods Act 2008
Name of regulation
This regulation is the Medicines, Poisons and Therapeutic Goods Amendment Regulation 2020 (No 3).
Commencement
This regulation commences on the day after its notification day.
NoteThe naming and commencement provisions automatically commence on the notification day (see Legislation Act, s 75 (1)).
Legislation amended
This regulation amends the Medicines, Poisons and Therapeutic Goods Regulation 2008.
Part 15.1 heading
substitute
Part 15.1Opioid dependency treatment
New sections 631 and 632
in part 15.1, insert
Minister may exempt certain people dealing with buprenorphine or methadone from Act—Act, s 190 (1) (b)
(1)The Minister may exempt a person from the Act if the person—
(a)is an agent of an ODT person; and
(b)is dealing with buprenorphine or methadone for the ODT person.
NoteAn exemption may be conditional (see the Act, s 190 (2)).
(2)An exemption is a disallowable instrument.
NoteA disallowable instrument must be notified, and presented to the Legislative Assembly, under the Legislation Act.
(3)In this section:
agent, of an ODT person, means a person nominated as the ODT person’s agent under the ODT contingency guidelines.
ODT contingency guidelines means guidelines issued under the Act, section 192 that make provision about the circumstances in which an agent for an ODT person may deal with buprenorphine or methadone for the ODT person.
ODT person means a person who—
(a)is dependent on opioids; and
(b)is being treated for their dependency with buprenorphine or methadone.
Certain people exempt from Act during COVID-19 emergency—Act, s 190 (1) (a)
(1)An agent of an ODT person is exempt from the Act if—
(a)the ODT person is unable to attend an opioid dependency treatment centre because of a COVID-19 emergency; and
(b)the agent is dealing with buprenorphine or methadone for the ODT person; and
(c)the agent complies with the ODT contingency guidelines when dealing with the buprenorphine or methadone for the ODT person.
Note 1Opioid dependency treatment centre—see the Act, dictionary.
Note 2Dealing with buprenorphine or methadone includes obtaining, possessing, supplying or discarding the substance (see the Act, s 19).
(2)In this section:
agent, of an ODT person—see section 631 (3).
COVID-19 emergency means—
(a)a state of emergency declared under the Emergencies Act 2004, section 156 because of the coronavirus disease 2019 (COVID‑19); or
(b)an emergency declared under the Public Health Act 1997, section 119 (including any extension or further extension) because of the coronavirus disease 2019 (COVID-19).
ODT contingency guidelines—see section 631 (3).
ODT person—see section 631 (3).
(3)This section expires on the first day no COVID-19 emergency is in force.
Dictionary, note 3, new dot point
insert
· opioid dependency treatment centre
Endnotes
Notification
Notified under the Legislation Act on 26 June 2020.
Republications of amended laws
For the latest republication of amended laws, see align="center">© Australian Capital Territory 2020
0
0
0